Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.

Completed

• Conditions: Gastroesophageal Reflux Disease

• Registration Number: NCT00786773
• Lead Sponsor: AstraZeneca

Brief Summary

To describe the change of impact of reflux symptoms on the everyday life perceived by patients before and after 4 weeks treatment by using GERD Impact Scale questionnaire (GIS) by total GERD patient population and by treatment group; and to describe the concordance between patient-reported and physician-reported symptom load.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-10
• Study First Submitted: 2008-11-05
• Study First Submitted QC: 2008-11-05
• Study First Posted: 2008-11-06
• Study Completion: 2009-06
• Status Verified: 2010-12
• Last Update Submitted: 2010-12-06
• Last Update Posted: 2010-12-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2091

Inclusion Criteria

• Patients with GERD diagnosed clinically or by endoscopy and prescribed with medical treatments
• Provision of written informed consent

Exclusion Criteria

• Patients cannot read and/or understand GIS
• Patients with the history or symptoms of peptic ulcer, gastrointestinal cancer, serious or malignant diseases (anorexia, weight loss, anemia, fever ...)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Type, frequency and severity of the GERD symptoms	4 weeks

Trial Locations

Locations (1)

Research Site; 🇻🇳 Thai binh, Vietnam